BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25821226)

  • 1. Ebola Virus Glycoprotein Promotes Enhanced Viral Egress by Preventing Ebola VP40 From Associating With the Host Restriction Factor BST2/Tetherin.
    Gustin JK; Bai Y; Moses AV; Douglas JL
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S181-90. PubMed ID: 25821226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of the Ebola Virus Proteins VP40 and GP
    Rizk MG; Basler CF; Guatelli J
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin.
    Kühl A; Banning C; Marzi A; Votteler J; Steffen I; Bertram S; Glowacka I; Konrad A; Stürzl M; Guo JT; Schubert U; Feldmann H; Behrens G; Schindler M; Pöhlmann S
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S850-60. PubMed ID: 21987761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection.
    Okumura A; Rasmussen AL; Halfmann P; Feldmann F; Yoshimura A; Feldmann H; Kawaoka Y; Harty RN; Katze MG
    J Virol; 2015 Oct; 89(20):10399-406. PubMed ID: 26246577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
    Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
    J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
    González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism.
    Vande Burgt NH; Kaletsky RL; Bates P
    Viruses; 2015 Oct; 7(10):5587-602. PubMed ID: 26516900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.
    Favier AL; Gout E; Reynard O; Ferraris O; Kleman JP; Volchkov V; Peyrefitte C; Thielens NM
    J Virol; 2016 Jun; 90(11):5256-5269. PubMed ID: 26984723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
    Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress.
    Han Z; Madara JJ; Liu Y; Liu W; Ruthel G; Freedman BD; Harty RN
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S138-45. PubMed ID: 25786915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.
    Lopez LA; Yang SJ; Exline CM; Rengarajan S; Haworth KG; Cannon PM
    J Virol; 2012 May; 86(10):5467-80. PubMed ID: 22398279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
    Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
    J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BST2/Tetherin enhances entry of human cytomegalovirus.
    Viswanathan K; Smith MS; Malouli D; Mansouri M; Nelson JA; Früh K
    PLoS Pathog; 2011 Nov; 7(11):e1002332. PubMed ID: 22072961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebola Virus Requires Phosphatidylserine Scrambling Activity for Efficient Budding and Optimal Infectivity.
    Acciani MD; Lay Mendoza MF; Havranek KE; Duncan AM; Iyer H; Linn OL; Brindley MA
    J Virol; 2021 Sep; 95(20):e0116521. PubMed ID: 34319156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin Ligase WWP1 Interacts with Ebola Virus VP40 To Regulate Egress.
    Han Z; Sagum CA; Takizawa F; Ruthel G; Berry CT; Kong J; Sunyer JO; Freedman BD; Bedford MT; Sidhu SS; Sudol M; Harty RN
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute respiratory syndrome coronavirus spike protein counteracts BST2-mediated restriction of virus-like particle release.
    Wang SM; Huang KJ; Wang CT
    J Med Virol; 2019 Oct; 91(10):1743-1750. PubMed ID: 31199522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of Immunomodulatory Ebola Virus Glycoprotein-Containing Microvesicles Is Suppressed by Tetherin in a Species-Specific Manner.
    Nehls J; Businger R; Hoffmann M; Brinkmann C; Fehrenbacher B; Schaller M; Maurer B; Schönfeld C; Kramer D; Hailfinger S; Pöhlmann S; Schindler M
    Cell Rep; 2019 Feb; 26(7):1841-1853.e6. PubMed ID: 30759394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the endosomal ESCRT machinery in HIV-1 Vpu-induced down-regulation of BST2/tetherin.
    Janvier K; Roy N; Berlioz-Torrent C
    Curr HIV Res; 2012 Jun; 10(4):315-20. PubMed ID: 22524180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
    Kaletsky RL; Francica JR; Agrawal-Gamse C; Bates P
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2886-91. PubMed ID: 19179289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC3C Contributes to Vpu-Mediated Antagonism of BST2/Tetherin Restriction on HIV-1 Release through a Non-canonical Autophagy Pathway.
    Madjo U; Leymarie O; Frémont S; Kuster A; Nehlich M; Gallois-Montbrun S; Janvier K; Berlioz-Torrent C
    Cell Rep; 2016 Nov; 17(9):2221-2233. PubMed ID: 27880899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.